Immune-mediated thrombocytopenia (ITP) is a serious condition in which the immune system destroys platelets, causing life-threatening bleeding. Prompt diagnosis and immunosuppression are essential welfare interventions.
ITP is a life-threatening condition that causes significant welfare concern from multiple angles. Active bleeding episodes cause pain, weakness, and distress — internal haemorrhage can be rapidly fatal. Dogs with very low platelet counts are at risk of sudden catastrophic bleeding from minor trauma or spontaneous internal haemorrhage. The treatment itself involves high-dose immunosuppression that causes significant side effects: polyuria, polydipsia, weight gain, muscle wasting, and increased infection risk. Monitoring for treatment response requires repeated blood sampling. Relapses after successful remission cause repeated cycles of acute illness and treatment burden. Despite these challenges, with appropriate management most dogs with ITP achieve good quality of life — the critical factor is prompt diagnosis before catastrophic bleeding occurs.